The WHI: The effect of hormone replacement therapy on fracture prevention

Climacteric

Volumn 15, Issue 3, 2012, Pages 263-266

  De Villiers, T J ^a   Stevenson, J C ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

HORMONE REPLACEMENT THERAPY; PREVENTION OF OSTEOPOROSIS RELATED FRACTURES; WOMEN'S HEALTH INITIATIVE STUDY

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

CLINICAL PRACTICE; DRESS SYNDROME; FRACTURE; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; WOMEN'S HEALTH;

AGE FACTORS; AGED; BONE DENSITY; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRACTURES, BONE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WOMEN'S HEALTH;

EID: 84861368012     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2012.659975     Document Type: Review

References (17)

1. Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980;303:1195-8 (Pubitemid 11207583)
2. Genant HK, Baylink DJ, Gallagher JC, Harris ST, Steiger P, Herber M. Effect of estrone sulfate on postmenopausal bone loss. Obstet Gynecol 1990;76:579-84 (Pubitemid 20322055)
3. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33 (Pubitemid 34761611)
4. Anderson GL, Limacher M, Assaf AR, et al . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12 (Pubitemid 38489892)
5. Cauley JA, Robbins J, Chen Z, et al . Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women'sHealth Initiative randomized trial. JAMA 2003;290:1729-38 (Pubitemid 37430623)
6. Jackson RD, Wactawski-Wende J, LaCroix AZ, et al. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the Women's Health Initiative randomized trial. J Bone Miner Res 2006;21:817-28 (Pubitemid 43787988)
7. Freedman L, Anderson G, Kipnis V, et al . Approaches to monitoring the results of long-term disease prevention trials: examples from the Women's Health Initiative. Controlled Clin Trials 1996;17:509-25 (Pubitemid 27033568)
8. Freedman L, Anderson G, Kipnis V, et al . Guidelines for the statistical monitoring of the Women's Health Initiative clinical trial. West J Med 1998;168:236-40
9. Anderson GL. WHI results withstand the test of time. Br Med J2010; rapid response 12 March
10. Cummings SR, Black DM, Thompson DE, et al . Effect of alendronate on the risk of fracture in women with low bone density but without vertebral fracture: results from Fracture Intervention Trial. JAMA 1998;280:2077-82 (Pubitemid 29014065)
11. Ettinger B, Black DM, Mitlak BH, et al. for the Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA 1999;282:637-45 (Pubitemid 29384151)
12. Kado DM, Browner WS, Palermo L, et al. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1998;159: 1215-20
13. LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011;305:1305-14
14. Stevenson JC. Prevention of osteoporosis; one step forward, two steps back. Menopause Int 2011;17:137-41
15. Stevenson JC on behalf of the International Consensus Group on HRT and Regulatory Issues. HRT, osteoporosis and regulatory authorities. Quis custodiet ipsos custodes? Hum Reprod 2006;21: 1668-71
16. Studd J. Estrogens as fi rst-choice therapy for osteoporosis prevention and treatment in women under 60. Climacteric 2009;12:206-9
17. Pines A, Sturdee DW, Birkhäuser MH, et al. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007;10:181-94 (Pubitemid 46752441)